Phase 1 Open-label Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of AMG 701 in Subjects With Multiple Myeloma

Type of Cancer
Multiple Myeloma

Site
Hackensack

Sponsor
Amgen

Protocol Number
20170122

Phase of Trial
Phase I

To Learn More Call
(201)-510-0950